688 related articles for article (PubMed ID: 32342519)
1. A robust six-miRNA prognostic signature for head and neck squamous cell carcinoma.
Zhao X; Cui L
J Cell Physiol; 2020 Nov; 235(11):8799-8811. PubMed ID: 32342519
[TBL] [Abstract][Full Text] [Related]
2. Construction of an 11-microRNA-based signature and a prognostic nomogram to predict the overall survival of head and neck squamous cell carcinoma patients.
Huang Y; Liu Z; Zhong L; Wen Y; Ye Q; Cao D; Li P; Liu Y
BMC Genomics; 2020 Oct; 21(1):691. PubMed ID: 33023466
[TBL] [Abstract][Full Text] [Related]
3. Six-MicroRNA Prognostic Signature in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma.
Worakitchanon W; Panvongsa W; Siripoon T; Kitdumrongthum S; Wongpan A; Arsa L; Trachu N; Jinawath N; Chairoungdua A; Ngamphaiboon N
JCO Precis Oncol; 2023 May; 7():e2300003. PubMed ID: 37163716
[TBL] [Abstract][Full Text] [Related]
4. Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas.
Wong N; Khwaja SS; Baker CM; Gay HA; Thorstad WL; Daly MD; Lewis JS; Wang X
Cancer Med; 2016 Jul; 5(7):1619-28. PubMed ID: 27109697
[TBL] [Abstract][Full Text] [Related]
5. Combined identification of three miRNAs in serum as effective diagnostic biomarkers for HNSCC.
Liu C; Yu Z; Huang S; Zhao Q; Sun Z; Fletcher C; Jiang Y; Zhang D
EBioMedicine; 2019 Dec; 50():135-143. PubMed ID: 31780396
[TBL] [Abstract][Full Text] [Related]
6. Immune-related miRNA signature identifies prognosis and immune landscape in head and neck squamous cell carcinomas.
Ma B; Li H; Qiao J; Meng T; Yu R
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33111959
[TBL] [Abstract][Full Text] [Related]
7. Prediction of radiotherapy response with a 5-microRNA signature-based nomogram in head and neck squamous cell carcinoma.
Chen L; Wen Y; Zhang J; Sun W; Lui VWY; Wei Y; Chen F; Wen W
Cancer Med; 2018 Mar; 7(3):726-735. PubMed ID: 29473326
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
Zhang F; Liu Y; Yang Y; Yang K
BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
[TBL] [Abstract][Full Text] [Related]
9. Identification of Tumor Suppressive Genes Regulated by
Oshima S; Asai S; Seki N; Minemura C; Kinoshita T; Goto Y; Kikkawa N; Moriya S; Kasamatsu A; Hanazawa T; Uzawa K
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34201353
[TBL] [Abstract][Full Text] [Related]
10. Identification of a nomogram based on an 8-lncRNA signature as a novel diagnostic biomarker for head and neck squamous cell carcinoma.
Mao R; Chen Y; Xiong L; Liu Y; Zhang T
Aging (Albany NY); 2020 Oct; 12(20):20778-20800. PubMed ID: 33091878
[TBL] [Abstract][Full Text] [Related]
11. Two miRNA prognostic signatures of head and neck squamous cell carcinoma: A bioinformatic analysis based on the TCGA dataset.
Wu C; Tong L; Wu C; Chen D; Chen J; Li Q; Jia F; Huang Z
Cancer Med; 2020 Apr; 9(8):2631-2642. PubMed ID: 32064753
[TBL] [Abstract][Full Text] [Related]
12. A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy-treated head and neck squamous cell carcinoma (HNSCC).
Wintergerst L; Selmansberger M; Maihoefer C; Schüttrumpf L; Walch A; Wilke C; Pitea A; Woischke C; Baumeister P; Kirchner T; Belka C; Ganswindt U; Zitzelsberger H; Unger K; Hess J
Mol Oncol; 2018 Dec; 12(12):2085-2101. PubMed ID: 30259648
[TBL] [Abstract][Full Text] [Related]
13. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N
Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of an alternative splicing-based prognostic signature for head and neck squamous cell carcinoma.
Zhao X; Si S; Li X; Sun W; Cui L
J Cancer; 2020; 11(15):4571-4580. PubMed ID: 32489474
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a novel ferroptosis-related gene signature for predicting prognosis and immune microenvironment in head and neck squamous cell carcinoma.
He F; Chen Z; Deng W; Zhan T; Huang X; Zheng Y; Yang H
Int Immunopharmacol; 2021 Sep; 98():107789. PubMed ID: 34130150
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Correlation of an Autophagy-Related Gene Signature in Patients with Head and Neck Squamous Cell Carcinoma.
Yang C; Mei H; Peng L; Jiang F; Xie B; Li J
Comput Math Methods Med; 2020; 2020():7397132. PubMed ID: 33456497
[TBL] [Abstract][Full Text] [Related]
17. A novel seven‑miRNA prognostic model to predict overall survival in head and neck squamous cell carcinoma patients.
Lu L; Wu Y; Feng M; Xue X; Fan Y
Mol Med Rep; 2019 Nov; 20(5):4340-4348. PubMed ID: 31545440
[TBL] [Abstract][Full Text] [Related]
18. Development and Validation of a Robust Immune Prognostic Signature for Head and Neck Squamous Cell Carcinoma.
Qiu Y; Cui L; Lin Y; Gao B; Li J; Zhao X; Zhu X; Hu S; Lin L
Front Oncol; 2020; 10():1502. PubMed ID: 33224866
[TBL] [Abstract][Full Text] [Related]
19. HOTTIP Functions as a Key Candidate Biomarker in Head and Neck Squamous Cell Carcinoma by Integrated Bioinformatic Analysis.
Yin X; Yang W; Xie J; Wei Z; Tang C; Song C; Wang Y; Cai Y; Xu W; Han W
Biomed Res Int; 2019; 2019():5450617. PubMed ID: 31032351
[TBL] [Abstract][Full Text] [Related]
20. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
Zhu W; Ye Z; Chen L; Liang H; Cai Q
Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
